Skip to main content
Erschienen in: Archives of Orthopaedic and Trauma Surgery 7/2010

01.07.2010 | Basic Science

The effects of high-dose, long-term alendronate treatment on microarchitecture and bone mineral density of compact and trabecular bone in the proximal femur of adult male rabbits

verfasst von: Jochen G. Hofstaetter, Jinxi Wang, Stefan G. Hofstaetter, Melvin J. Glimcher

Erschienen in: Archives of Orthopaedic and Trauma Surgery | Ausgabe 7/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Despite the widespread use of bisphosphonates, its effects on normal bone microarchitecture of the proximal femur are still poorly studied. The purpose of this study was to determine the effects of long-term high-dose treatment of alendronate on microstructure and bone mineral density of cancellous, cortical compact and subchondral compact bone of the femoral head and neck region in normal adult male rabbits.

Materials and methods

Thirty-two adult, male rabbits were randomized into and were treated with either alendronate or placebo for 6 and 12 months. Micro-QCT measurements were taken in the (1) trabecular region, (2) cortical region of the femoral neck and (3) the subchondral region of the femoral head.

Results

In the trabecular region of the femoral head, alendronate treatment significantly increased vBMD at 6 and 12 months (+21.0%, p < 0.05 and +26.8%, p < 0.05, respectively) and BVF (29.6%, p < 0.05 and 35.6%, p < 0.05, respectively) with significantly altered bone microarchitecture when compared with their placebo group; 6- and 12-month alendronate treatment significantly increased the vBMD and thickness and decreased the porosity of the subchondral bone in the femoral head.

Conclusion

High-dose alendronate treatment led to significant and differential changes in bone microarchitecture in trabecular, cortical and subchondral bone of the proximal femur of adult male rabbits.
Literatur
1.
Zurück zum Zitat Orwoll ES (2006) Osteoporosis in men. Primer on the metabolic bone diseases and disorders of mineral metabolism, 6th edn. ASBMR, Washington, DC, pp 290–293 Orwoll ES (2006) Osteoporosis in men. Primer on the metabolic bone diseases and disorders of mineral metabolism, 6th edn. ASBMR, Washington, DC, pp 290–293
2.
Zurück zum Zitat Melton LJ 3rd (1988) Epidemiology of Fractures. In: Riggs BL, Melton LJ 3rd (eds) Osteoporosis: etiology, diagnosis and management. Raven Press, New York Melton LJ 3rd (1988) Epidemiology of Fractures. In: Riggs BL, Melton LJ 3rd (eds) Osteoporosis: etiology, diagnosis and management. Raven Press, New York
3.
Zurück zum Zitat Stresing V, Daubine F, Benzaid I, Monkkonen H, Clezardin P (2007) Bisphosphonates in cancer therapy. Cancer Lett 257(1):16–35CrossRefPubMed Stresing V, Daubine F, Benzaid I, Monkkonen H, Clezardin P (2007) Bisphosphonates in cancer therapy. Cancer Lett 257(1):16–35CrossRefPubMed
4.
Zurück zum Zitat Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. JAMA 282(14):1344–1352CrossRefPubMed Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. JAMA 282(14):1344–1352CrossRefPubMed
5.
Zurück zum Zitat Black DM, DE Thompson, Bauer DC, Ensrud K, Musliner T, Hochberg MC et al (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85(11):4118–4124CrossRefPubMed Black DM, DE Thompson, Bauer DC, Ensrud K, Musliner T, Hochberg MC et al (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85(11):4118–4124CrossRefPubMed
6.
Zurück zum Zitat Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM (2003) The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349(13):1216–1226CrossRefPubMed Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM (2003) The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349(13):1216–1226CrossRefPubMed
7.
Zurück zum Zitat Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285(3):320–323CrossRefPubMed Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285(3):320–323CrossRefPubMed
8.
Zurück zum Zitat Watts NBR, Smith C, Li Z, Eastell R, Pack S, Lindsay R (2000) BMD changes explains only a fraction of the observed fracture risk reduction in risedronate-treated patients. Osteoporos Int 11(Suppl 2)(546):S203 Watts NBR, Smith C, Li Z, Eastell R, Pack S, Lindsay R (2000) BMD changes explains only a fraction of the observed fracture risk reduction in risedronate-treated patients. Osteoporos Int 11(Suppl 2)(546):S203
9.
Zurück zum Zitat Miller PD, McClung M (1996) Prediction of fracture risk. I: Bone density. Am J Med Sci 312(6):257–259CrossRefPubMed Miller PD, McClung M (1996) Prediction of fracture risk. I: Bone density. Am J Med Sci 312(6):257–259CrossRefPubMed
10.
Zurück zum Zitat Fratzl P, Gupta HS, Paschalis EP, Roschger P (2004) Structure and mechanical quality of the collagen-mineral nano-composite in bone. J Mater Chem 14:2115–2123CrossRef Fratzl P, Gupta HS, Paschalis EP, Roschger P (2004) Structure and mechanical quality of the collagen-mineral nano-composite in bone. J Mater Chem 14:2115–2123CrossRef
11.
Zurück zum Zitat Roschger P, Paschalis EP, Fratzl P, Klaushofer K (2008) Bone mineralization density distribution in health and disease. Bone 42(3):456–466CrossRefPubMed Roschger P, Paschalis EP, Fratzl P, Klaushofer K (2008) Bone mineralization density distribution in health and disease. Bone 42(3):456–466CrossRefPubMed
12.
Zurück zum Zitat (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285(6):785–795 (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285(6):785–795
13.
Zurück zum Zitat Rodan G, Reszka A, Golub E, Rizzoli R (2004) Bone safety of long-term bisphosphonate treatment. Curr Med Res Opin 20(8):1291–1300CrossRefPubMed Rodan G, Reszka A, Golub E, Rizzoli R (2004) Bone safety of long-term bisphosphonate treatment. Curr Med Res Opin 20(8):1291–1300CrossRefPubMed
14.
Zurück zum Zitat Roschger P, Rinnerthaler S, Yates J, Rodan GA, Fratzl P, Klaushofer K (2001) Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone 29(2):185–191CrossRefPubMed Roschger P, Rinnerthaler S, Yates J, Rodan GA, Fratzl P, Klaushofer K (2001) Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone 29(2):185–191CrossRefPubMed
15.
Zurück zum Zitat Misof BM, Roschger P, Baldini T, Raggio CL, Zraick V, Root L et al (2005) Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse. Bone 36(1):150–158CrossRefPubMed Misof BM, Roschger P, Baldini T, Raggio CL, Zraick V, Root L et al (2005) Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse. Bone 36(1):150–158CrossRefPubMed
16.
Zurück zum Zitat Keaveny TM, Donley DW, Hoffmann PF, Mitlak BH, Glass EV, San Martin JA (2007) Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis. J Bone Miner Res 22(1):149–157CrossRefPubMed Keaveny TM, Donley DW, Hoffmann PF, Mitlak BH, Glass EV, San Martin JA (2007) Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis. J Bone Miner Res 22(1):149–157CrossRefPubMed
17.
Zurück zum Zitat Mashiba T, Turner CH, Hirano T, Forwood MR, Johnston CC, Burr DB (2001) Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 28(5):524–531CrossRefPubMed Mashiba T, Turner CH, Hirano T, Forwood MR, Johnston CC, Burr DB (2001) Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 28(5):524–531CrossRefPubMed
18.
Zurück zum Zitat Mosekilde L, Thomsen JS, Mackey MS, Phipps RJ (2000) Treatment with risedronate or alendronate prevents hind-limb immobilization-induced loss of bone density and strength in adult female rats. Bone 27(5):639–645CrossRefPubMed Mosekilde L, Thomsen JS, Mackey MS, Phipps RJ (2000) Treatment with risedronate or alendronate prevents hind-limb immobilization-induced loss of bone density and strength in adult female rats. Bone 27(5):639–645CrossRefPubMed
19.
Zurück zum Zitat Pataki A, Muller K, Green JR, Ma YF, Li QN, Jee WS (1997) Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: a comparative histomorphometric study on the cancellous bone formed before, during, and after treatment. Anat Rec 249(4):458–468CrossRefPubMed Pataki A, Muller K, Green JR, Ma YF, Li QN, Jee WS (1997) Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: a comparative histomorphometric study on the cancellous bone formed before, during, and after treatment. Anat Rec 249(4):458–468CrossRefPubMed
20.
Zurück zum Zitat Kippo K, Hannuniemi R, Isaksson P, Lauren L, Osterman T, Peng Z et al (1998) Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats. J Bone Miner Res 13(2):287–296CrossRefPubMed Kippo K, Hannuniemi R, Isaksson P, Lauren L, Osterman T, Peng Z et al (1998) Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats. J Bone Miner Res 13(2):287–296CrossRefPubMed
21.
Zurück zum Zitat Kobayashi S, Shimizu T, Mehdi R, Nawata M, Kojima S, Tsutsumimoto T et al (1999) Advantages of concurrent use of anabolic and antiresorptive agents over single use of these agents in increasing trabecular bone volume, connectivity, and biomechanical competence of rat vertebrae. Bone 25(6):703–712CrossRefPubMed Kobayashi S, Shimizu T, Mehdi R, Nawata M, Kojima S, Tsutsumimoto T et al (1999) Advantages of concurrent use of anabolic and antiresorptive agents over single use of these agents in increasing trabecular bone volume, connectivity, and biomechanical competence of rat vertebrae. Bone 25(6):703–712CrossRefPubMed
22.
Zurück zum Zitat Komatsubara S, Mori S, Mashiba T, Ito M, Li J, Kaji Y et al (2003) Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra. J Bone Miner Res 18(3):512–520CrossRefPubMed Komatsubara S, Mori S, Mashiba T, Ito M, Li J, Kaji Y et al (2003) Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra. J Bone Miner Res 18(3):512–520CrossRefPubMed
23.
Zurück zum Zitat Ding M, Day JS, Burr DB, Mashiba T, Hirano T, Weinans H et al (2003) Canine cancellous bone microarchitecture after one year of high-dose bisphosphonates. Calcif Tissue Int 72(6):737–744CrossRefPubMed Ding M, Day JS, Burr DB, Mashiba T, Hirano T, Weinans H et al (2003) Canine cancellous bone microarchitecture after one year of high-dose bisphosphonates. Calcif Tissue Int 72(6):737–744CrossRefPubMed
24.
Zurück zum Zitat McCreadie BR, Goulet RW, Feldkamp LA, Goldstein SA (2001) Hierarchical structure of bone and micro-computed tomography. Adv Exp Med Biol 496:67–83PubMed McCreadie BR, Goulet RW, Feldkamp LA, Goldstein SA (2001) Hierarchical structure of bone and micro-computed tomography. Adv Exp Med Biol 496:67–83PubMed
25.
Zurück zum Zitat Barou O, Valentin D, Vico L, Tirode C, Barbier A, Alexandre C et al (2002) High-resolution three-dimensional micro-computed tomography detects bone loss and changes in trabecular architecture early: comparison with DEXA and bone histomorphometry in a rat model of disuse osteoporosis. Invest Radiol 37(1):40–46CrossRefPubMed Barou O, Valentin D, Vico L, Tirode C, Barbier A, Alexandre C et al (2002) High-resolution three-dimensional micro-computed tomography detects bone loss and changes in trabecular architecture early: comparison with DEXA and bone histomorphometry in a rat model of disuse osteoporosis. Invest Radiol 37(1):40–46CrossRefPubMed
26.
Zurück zum Zitat Ding M, Odgaard A, Hvid I (2003) Changes in the three-dimensional microstructure of human tibial cancellous bone in early osteoarthritis. J Bone Joint Surg Br 85(6):906–912PubMed Ding M, Odgaard A, Hvid I (2003) Changes in the three-dimensional microstructure of human tibial cancellous bone in early osteoarthritis. J Bone Joint Surg Br 85(6):906–912PubMed
27.
Zurück zum Zitat Batiste DL, Kirkley A, Laverty S, Thain LM, Spouge AR, Gati JS et al (2004) High-resolution MRI and micro-CT in an ex vivo rabbit anterior cruciate ligament transection model of osteoarthritis. Osteoarthritis Cartilage 12(8):614–626CrossRefPubMed Batiste DL, Kirkley A, Laverty S, Thain LM, Spouge AR, Gati JS et al (2004) High-resolution MRI and micro-CT in an ex vivo rabbit anterior cruciate ligament transection model of osteoarthritis. Osteoarthritis Cartilage 12(8):614–626CrossRefPubMed
28.
Zurück zum Zitat Wachsmuth L, Engelke K (2004) High-resolution imaging of osteoarthritis using microcomputed tomography. Methods Mol Med 101:231–248PubMed Wachsmuth L, Engelke K (2004) High-resolution imaging of osteoarthritis using microcomputed tomography. Methods Mol Med 101:231–248PubMed
29.
Zurück zum Zitat Hofstaetter JG, Wang J, Yan J, Glimcher MJ (2006) Changes in bone microarchitecture and bone mineral density following experimental osteonecrosis of the hip in rabbits. Cells Tissues Organs 184(3–4):138–147CrossRefPubMed Hofstaetter JG, Wang J, Yan J, Glimcher MJ (2006) Changes in bone microarchitecture and bone mineral density following experimental osteonecrosis of the hip in rabbits. Cells Tissues Organs 184(3–4):138–147CrossRefPubMed
30.
Zurück zum Zitat Thompson DD, Seedor JG, Quartuccio H, Solomon H, Fioravanti C, Davidson J et al (1992) The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboons. J Bone Miner Res 7(8):951–960CrossRefPubMed Thompson DD, Seedor JG, Quartuccio H, Solomon H, Fioravanti C, Davidson J et al (1992) The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboons. J Bone Miner Res 7(8):951–960CrossRefPubMed
31.
Zurück zum Zitat Thompson DD, Simmons HA, Pirie CM, Ke HZ (1995) FDA guidelines and animal models for osteoporosis. Bone 17(4 Suppl):125S–133SPubMed Thompson DD, Simmons HA, Pirie CM, Ke HZ (1995) FDA guidelines and animal models for osteoporosis. Bone 17(4 Suppl):125S–133SPubMed
32.
Zurück zum Zitat Mosekilde L (1995) Assessing bone quality–animal models in preclinical osteoporosis research. Bone 17(4 Suppl):343S–352SPubMed Mosekilde L (1995) Assessing bone quality–animal models in preclinical osteoporosis research. Bone 17(4 Suppl):343S–352SPubMed
33.
Zurück zum Zitat Rodgers JB, Monier-Faugere MC, Malluche H (1993) Animal models for the study of bone loss after cessation of ovarian function. Bone 14(3):369–377CrossRefPubMed Rodgers JB, Monier-Faugere MC, Malluche H (1993) Animal models for the study of bone loss after cessation of ovarian function. Bone 14(3):369–377CrossRefPubMed
34.
Zurück zum Zitat Kimmel DB (2001) Animal models for in vivo experimentation in osteoporosis research. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, San Diego, pp 29–47CrossRef Kimmel DB (2001) Animal models for in vivo experimentation in osteoporosis research. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, San Diego, pp 29–47CrossRef
35.
Zurück zum Zitat Gilsanz V, Roe TF, Gibbens DT, Schulz EE, Carlson ME, Gonzalez O et al (1988) Effect of sex steroids on peak bone density of growing rabbits. Am J Physiol 255(4 Pt 1):E416–E421PubMed Gilsanz V, Roe TF, Gibbens DT, Schulz EE, Carlson ME, Gonzalez O et al (1988) Effect of sex steroids on peak bone density of growing rabbits. Am J Physiol 255(4 Pt 1):E416–E421PubMed
36.
Zurück zum Zitat Rao DR, Sunki GR, Johnson WM, Chen CP (1977) Postnatal Growth of New Zealand White Rabbit (Oryctolagus cuniculus). J Anim Sci 44:1021–1025PubMed Rao DR, Sunki GR, Johnson WM, Chen CP (1977) Postnatal Growth of New Zealand White Rabbit (Oryctolagus cuniculus). J Anim Sci 44:1021–1025PubMed
37.
Zurück zum Zitat Hofstaetter JG, Wang J, Yan J, Glimcher MJ (2008) The effects of alendronate in the treatment of experimental osteonecrosis of the hip in adult rabbits. Osteoarthritis Cartilage Hofstaetter JG, Wang J, Yan J, Glimcher MJ (2008) The effects of alendronate in the treatment of experimental osteonecrosis of the hip in adult rabbits. Osteoarthritis Cartilage
38.
Zurück zum Zitat Peter C, Rodan GA (1999) Preclinical safety profile of alendronate. Int J Clin Pract Suppl 101:3–8PubMed Peter C, Rodan GA (1999) Preclinical safety profile of alendronate. Int J Clin Pract Suppl 101:3–8PubMed
39.
Zurück zum Zitat Migliorati CA, Schubert MM, Peterson DE, Seneda LM (2005) Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104(1):83–93CrossRefPubMed Migliorati CA, Schubert MM, Peterson DE, Seneda LM (2005) Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104(1):83–93CrossRefPubMed
40.
Zurück zum Zitat Otsu N (1979) A threshold selection method from gray-level histograms. IEEE Trans Syst Man Cyber 9:62–66CrossRef Otsu N (1979) A threshold selection method from gray-level histograms. IEEE Trans Syst Man Cyber 9:62–66CrossRef
41.
Zurück zum Zitat Sawka AM, Thabane L, Papaioannou A, Gafni A, Hanley DA, Adachi JD (2005) A systematic review of the effect of alendronate on bone mineral density in men. J Clin Densitom 8(1):7–13CrossRefPubMed Sawka AM, Thabane L, Papaioannou A, Gafni A, Hanley DA, Adachi JD (2005) A systematic review of the effect of alendronate on bone mineral density in men. J Clin Densitom 8(1):7–13CrossRefPubMed
42.
Zurück zum Zitat Grynpas MD, Alpert B, Katz I, Lieberman I, Pritzker KP (1991) Subchondral bone in osteoarthritis. Calcif Tissue Int 49(1):20–26CrossRefPubMed Grynpas MD, Alpert B, Katz I, Lieberman I, Pritzker KP (1991) Subchondral bone in osteoarthritis. Calcif Tissue Int 49(1):20–26CrossRefPubMed
43.
Zurück zum Zitat Hayami T, Pickarski M, Wesolowski GA, McLane J, Bone A, Destefano J et al (2004) The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 50(4):1193–1206CrossRefPubMed Hayami T, Pickarski M, Wesolowski GA, McLane J, Bone A, Destefano J et al (2004) The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 50(4):1193–1206CrossRefPubMed
44.
Zurück zum Zitat Feik SA, Thomas CD, Clement JG (1997) Age-related changes in cortical porosity of the midshaft of the human femur. J Anat 191(Pt 3):407–416CrossRefPubMed Feik SA, Thomas CD, Clement JG (1997) Age-related changes in cortical porosity of the midshaft of the human femur. J Anat 191(Pt 3):407–416CrossRefPubMed
45.
Zurück zum Zitat Bell KL, Loveridge N, Power J, Garrahan N, Stanton M, Lunt M et al (1999) Structure of the femoral neck in hip fracture: cortical bone loss in the inferoanterior to superoposterior axis. J Bone Miner Res 14(1):111–119CrossRefPubMed Bell KL, Loveridge N, Power J, Garrahan N, Stanton M, Lunt M et al (1999) Structure of the femoral neck in hip fracture: cortical bone loss in the inferoanterior to superoposterior axis. J Bone Miner Res 14(1):111–119CrossRefPubMed
46.
Zurück zum Zitat Ding M, Hvid I (2000) Quantification of age-related changes in the structure model type and trabecular thickness of human tibial cancellous bone. Bone 26(3):291–295CrossRefPubMed Ding M, Hvid I (2000) Quantification of age-related changes in the structure model type and trabecular thickness of human tibial cancellous bone. Bone 26(3):291–295CrossRefPubMed
47.
Zurück zum Zitat Holzer G, Skrbensky G, Holzer L, Pichl W (2008) Hip fractures and the contribution of cortical versus trabecular bone to femoral neck stability. J Bone Miner Res Holzer G, Skrbensky G, Holzer L, Pichl W (2008) Hip fractures and the contribution of cortical versus trabecular bone to femoral neck stability. J Bone Miner Res
48.
Zurück zum Zitat Cooper D, Turinsky A, Sensen C, Hallgrimsson B (2007) Effect of voxel size on 3D micro-CT analysis of cortical bone porosity. Calcif Tissue Int 80(3):211–219CrossRefPubMed Cooper D, Turinsky A, Sensen C, Hallgrimsson B (2007) Effect of voxel size on 3D micro-CT analysis of cortical bone porosity. Calcif Tissue Int 80(3):211–219CrossRefPubMed
49.
Zurück zum Zitat Currey JD (1990) Physical characteristics affecting the tensile failure properties of compact bone. J Biomech 23(8):837–844CrossRefPubMed Currey JD (1990) Physical characteristics affecting the tensile failure properties of compact bone. J Biomech 23(8):837–844CrossRefPubMed
Metadaten
Titel
The effects of high-dose, long-term alendronate treatment on microarchitecture and bone mineral density of compact and trabecular bone in the proximal femur of adult male rabbits
verfasst von
Jochen G. Hofstaetter
Jinxi Wang
Stefan G. Hofstaetter
Melvin J. Glimcher
Publikationsdatum
01.07.2010
Verlag
Springer-Verlag
Erschienen in
Archives of Orthopaedic and Trauma Surgery / Ausgabe 7/2010
Print ISSN: 0936-8051
Elektronische ISSN: 1434-3916
DOI
https://doi.org/10.1007/s00402-010-1116-1

Weitere Artikel der Ausgabe 7/2010

Archives of Orthopaedic and Trauma Surgery 7/2010 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.